MedTrace Logo

Caffeine/Propranolol Intervention for Acute Migraine

NCT01080677 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-02-24

Study results available
· View outcomes & findings →

Summary

This is a research study to assess the safety of caffeine/propranolol at different dose levels. We want to find out what effects, good and/or bad, it has on patients and their migraines.

Conditions

  • Migraine Disorders

Interventions

DRUG

caffeine/propranolol combination tablet

caffeine/propranolol combination tablet administered orally once daily

DRUG

placebo

placebo to match caffeine/propranolol combination tablet administered orally once daily

Sponsors & Collaborators

Principal Investigators

  • S. Charles Cho · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-09-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01080677 on ClinicalTrials.gov